Efficacy and safety of micronised fenofibrate in a randomised double-blind study comparing four doses from 200 mg to 400 mg daily with placebo in patients with hypercholesterolemia.

Source:http://linkedlifedata.com/resource/pubmed/id/10880891

Download in:

View as

General Info

PMID
10880891